Zentalis Pharmaceuticals, Inc. (ZNTL)
3.80
-0.08
(-2.06%)
USD |
NASDAQ |
Aug 28, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals 1 Year Total Returns (Daily) : 115.9% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 115.9% |
| August 27, 2026 | 113.2% |
| August 26, 2026 | 110.3% |
| August 25, 2026 | 113.2% |
| August 24, 2026 | 88.94% |
| August 21, 2026 | 104.5% |
| August 20, 2026 | 134.1% |
| August 19, 2026 | 140.3% |
| August 18, 2026 | 124.4% |
| August 17, 2026 | 133.0% |
| August 14, 2026 | 140.5% |
| August 13, 2026 | 178.5% |
| August 12, 2026 | 204.3% |
| August 11, 2026 | 193.6% |
| August 10, 2026 | 188.2% |
| August 07, 2026 | 191.0% |
| August 06, 2026 | 262.3% |
| August 05, 2026 | 251.1% |
| August 04, 2026 | 251.1% |
| August 03, 2026 | 247.0% |
| July 31, 2026 | 243.5% |
| July 30, 2026 | 256.5% |
| July 29, 2026 | 245.9% |
| July 28, 2026 | 220.8% |
| July 27, 2026 | 206.8% |
| Date | Value |
|---|---|
| July 24, 2026 | 194.6% |
| July 23, 2026 | 194.7% |
| July 22, 2026 | 214.7% |
| July 21, 2026 | 260.4% |
| July 20, 2026 | 255.3% |
| July 17, 2026 | 254.9% |
| July 16, 2026 | 228.8% |
| July 15, 2026 | 256.7% |
| July 14, 2026 | 250.7% |
| July 13, 2026 | 247.4% |
| July 10, 2026 | 256.2% |
| July 09, 2026 | 258.8% |
| July 08, 2026 | 282.7% |
| July 07, 2026 | 301.7% |
| July 06, 2026 | 274.6% |
| July 02, 2026 | 259.7% |
| July 01, 2026 | 266.0% |
| June 30, 2026 | 318.1% |
| June 29, 2026 | 290.7% |
| June 26, 2026 | 220.6% |
| June 25, 2026 | 189.3% |
| June 24, 2026 | 194.1% |
| June 23, 2026 | 183.1% |
| June 22, 2026 | 182.3% |
| June 18, 2026 | 168.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ARS Pharmaceuticals, Inc. | -54.20% |
| ACADIA Pharmaceuticals, Inc. | 10.98% |
| Alnylam Pharmaceuticals, Inc. | -47.58% |
| Anika Therapeutics, Inc. | 128.6% |
| Savara, Inc. | 60.86% |